Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Yuhua Li currently manages 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner working in 1 distinct art unit. The concentration of the portfolio in 1 technology area suggests a specific focus for the current intellectual property efforts. This lack of diversification across art units means that all active matters are subject to the same administrative oversight and examination environment within the patent office.
NEAGU, IRINA is identified as the busiest examiner for the portfolio, responsible for 1 pending office action. This individual is the sole examiner currently reviewing the patent applications. Because there is only 1 pending action, the immediate prosecution success is entirely dependent on the decisions made by this 1 examiner. This consolidated workload allows for a very targeted approach to the patent office interactions, focusing all resources on a single point of review.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| NEAGU, IRINA | 1 | 46.8% | +57.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18568043 | SAFE USE OF MMP-12 INHIBITOR | NEAGU, IRINA | 9d overdue |
| Art Unit | Apps |
|---|---|
| 1629 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18568043 | SAFE USE OF MMP-12 INHIBITOR | NEAGU, IRINA | 1629 | §103DP | Final Rejection | 9d overdue | Pending | Dec 07, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial